Loading organizations...
Loading organizations...
Develops safer, more effective cancer drugs using antibody technologies.
BioAtla has raised $147.5M across 3 funding rounds.
BioAtla has raised $147.5M in total across 3 funding rounds.
BioAtla has raised $147.5M in total across 3 funding rounds.
BioAtla's investors include HBM Healthcare Investments, Soleus Capital, Boxer Capital, Cormorant Asset Management, Farallon Capital Management, Janus Henderson Investors, Pappas Capital, Global BIO.
BioAtla has raised $147.5M across 3 funding rounds. Most recently, it raised $72.5M Series D in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 15, 2020 | $72.5M Series D | HBM Healthcare Investments, Soleus Capital | Boxer Capital, Cormorant Asset Management, Farallon Capital Management, Janus Henderson Investors, Pappas Capital |
| Jan 11, 2016 | $45.0M Debt / Other Equity | Global BIO | |
| Jun 11, 2015 | $30.0M Other Equity |